Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M.

EuroIntervention. 2017 Jan 20;12(13):1667-1673. doi: 10.4244/EIJ-D-15-00412.

2.

Comparison of Bailout and Planned Rotational Atherectomy for Heavily Calcified Coronary Lesions: A Single-Center Experience.

Allali A, Abdel-Wahab M, Sulimov DS, Jose J, Geist V, Kassner G, Richardt G, Toelg R.

J Interv Cardiol. 2017 Apr;30(2):124-133. doi: 10.1111/joic.12361. Epub 2016 Dec 19.

PMID:
27990696
3.

Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience.

Allali A, El-Mawardy M, Schwarz B, Sato T, Geist V, Toelg R, Richardt G, Abdel-Wahab M.

Cardiovasc Revasc Med. 2016 Sep;17(6):391-8. doi: 10.1016/j.carrev.2016.05.010. Epub 2016 Jun 17.

PMID:
27396607
4.

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.

Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Onuma Y, Garcia-Garcia HM, Waksman R.

Eur Heart J. 2016 Sep 14;37(35):2701-9. doi: 10.1093/eurheartj/ehw196. Epub 2016 May 17.

5.

Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.

de Waha S, Allali A, Büttner HJ, Toelg R, Geist V, Neumann FJ, Khattab AA, Richardt G, Abdel-Wahab M.

Catheter Cardiovasc Interv. 2016 Mar;87(4):691-700. doi: 10.1002/ccd.26290. Epub 2015 Nov 3.

PMID:
26525804
6.

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.

Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Garcia-Garcia HM, Waksman R.

Lancet. 2016 Jan 2;387(10013):31-9. doi: 10.1016/S0140-6736(15)00447-X. Epub 2015 Oct 12.

PMID:
26470647
7.

1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.

Abdel-Wahab M, Neumann FJ, Mehilli J, Frerker C, Richardt D, Landt M, Jose J, Toelg R, Kuck KH, Massberg S, Robinson DR, El-Mawardy M, Richardt G; CHOICE Investigators.

J Am Coll Cardiol. 2015 Aug 18;66(7):791-800. doi: 10.1016/j.jacc.2015.06.026.

8.

High-speed rotational atherectomy of the left main coronary artery: a single-center experience in 50 high-risk patients.

Sulimov DS, Abdel-Wahab M, Toelg R, Kassner G, Geist V, Richardt G.

Cardiovasc Revasc Med. 2015 Jul-Aug;16(5):284-9. doi: 10.1016/j.carrev.2015.05.002. Epub 2015 May 16.

PMID:
26070635
9.

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial.

Akin I, Khattab AA, Büttner HJ, Toelg R, Geist V, Neumann FJ, Richardt G, Abdel-Wahab M.

EuroIntervention. 2014 Aug;10(4):458-65. doi: 10.4244/EIJV10I4A79.

10.

Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single-center experience.

El-Mawardy M, Wübken-Kleinfeld N, Schwarz B, Gordian K, Stöcker B, Sier H, Toelg R, Geist V, Kraatz EG, Richardt G, Abdel-Wahab M.

Clin Res Cardiol. 2014 Aug;103(8):621-30. doi: 10.1007/s00392-014-0691-5. Epub 2014 Mar 11.

PMID:
24615477
11.

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry.

Toelg R, Merkely B, Erglis A, Hoffman S, Bruno H, Kornowski R, Slagboom T, Naber C, Witzenbichler B, Graf K, Richardt G, Hehrlein C; DELUX investigators.

EuroIntervention. 2014 Sep;10(5):591-9. doi: 10.4244/EIJV10I5A102.

12.

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G; Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators.

Lancet. 2013 Nov 16;382(9905):1638-45. doi: 10.1016/S0140-6736(13)61783-3. Epub 2013 Sep 3.

PMID:
24011548
13.

Long-term follow-up of coronary venous bypass graft lesions treated with a new generation drug-eluting stent with bioabsorbable polymer.

Wessely R, Marzocchi A, Schwacke H, Bertel O, Laanmets P, Perisic Z, Toelg R, Jagic N, Elsässer A, Danzi GB.

J Interv Cardiol. 2013 Oct;26(5):425-33. doi: 10.1111/joic.12056. Epub 2013 Aug 20.

PMID:
23962106
14.

Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.

Richardt G, Leschke M, Abdel-Wahab M, Toelg R, El-Mawardy M, Serruys PW, Silber S, Windecker S, Belardi JA, Neumann FJ, Widimsky P; RESOLUTE All Comers; RESOLUTE International Investigators.

JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.

15.

Aortic regurgitation and left ventricular remodeling after transcatheter aortic valve implantation: a serial cardiac magnetic resonance imaging study.

Merten C, Beurich HW, Zachow D, Mostafa AE, Geist V, Toelg R, Richardt G, Abdel-Wahab M.

Circ Cardiovasc Interv. 2013 Aug;6(4):476-83. doi: 10.1161/CIRCINTERVENTIONS.112.000115. Epub 2013 Aug 13. Erratum in: Circ Cardiovasc Interv. 2017 Nov;10 (11):.

16.

Stuck rotablator: the nightmare of rotational atherectomy.

Sulimov DS, Abdel-Wahab M, Toelg R, Kassner G, Geist V, Richardt G.

EuroIntervention. 2013 Jun 22;9(2):251-8. doi: 10.4244/EIJV9I2A41. Review.

17.

Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents.

Seivani Y, Abdel-Wahab M, Geist V, Richardt G, Sulimov DS, El-Mawardy M, Toelg R, Akin I.

Clin Res Cardiol. 2013 Nov;102(11):799-806. doi: 10.1007/s00392-013-0592-z. Epub 2013 Jun 16.

PMID:
23771774
18.

High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial.

Abdel-Wahab M, Richardt G, Joachim Büttner H, Toelg R, Geist V, Meinertz T, Schofer J, King L, Neumann FJ, Khattab AA.

JACC Cardiovasc Interv. 2013 Jan;6(1):10-9. doi: 10.1016/j.jcin.2012.07.017. Epub 2012 Dec 19.

19.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

20.

Longitudinal deformation of contemporary coronary stents: an integrated analysis of clinical experience and observations from the bench.

Abdel-Wahab M, Sulimov DS, Kassner G, Geist V, Toelg R, Richardt G.

J Interv Cardiol. 2012 Dec;25(6):576-85. doi: 10.1111/j.1540-8183.2012.00765.x. Epub 2012 Sep 28.

PMID:
23017115

Supplemental Content

Loading ...
Support Center